Overview

Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms

Status:
Completed

Trial end date:
2011-04-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the clinical efficacy and safety of tamsulosin alone or in combination with solifenacin for the treatment in men with lower urinary tract symptoms (LUTS) including overactive bladder (OAB) symptoms in Taiwan.

Phase:

Phase 4

Details

Lead Sponsor:

Astellas Pharma Taiwan, Inc.

Treatments:

Solifenacin Succinate
Tamsulosin